Study of REGN1193 in Patients With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety
and tolerability of REGN1193 in patients with Type 2 Diabetes Mellitus.